Top

Published in:

01-09-2020 | Sympathectomy | Clinical Image

Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis

Authors: Ashraful Haque, Trevor Cleveland, Lewis Powell, Sarah Stephenson, Michael Hughes, Rachael Kilding

Published in: Clinical Rheumatology | Issue 9/2020

Excerpt

A 60-year-old lady with known limited cutaneous SSc (anti-centromere antibody positive) and a history of severe digital vascular disease presented with progressive digital vascular ischaemia. Her history included bilateral (periarterial) sympathectomy and digital amputation. She had no modifiable cardiovascular risk factors and was taking sildenafil for SSc-digital vasculopathy. …

Hughes M, Allanore Y, Chung L, Pauling JD, Denton CP, Matucci-Cerinic M (2020) Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat Rev Rheumatol 16:208–221. https://doi.org/10.1038/s41584-020-0386-4CrossRefPubMed

Hughes M, Ong VH, Anderson ME, Hall F, Moinzadeh P, Griffiths B, Baildam E, Denton CP, Herrick AL (2015) Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis. Rheumatology (Oxford) 54(11):2015–2024CrossRef

Sharp CA, Akram Q, Hughes M, Muir L, Herrick AL (2016) Differential diagnosis of critical digital ischemia in systemic sclerosis: report of five cases and review of the literature. Semin Arthritis Rheum 46(2):209–216CrossRef

Title: Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis
Authors: Ashraful Haque
Trevor Cleveland
Lewis Powell
Sarah Stephenson
Michael Hughes
Rachael Kilding
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Sympathectomy
Systemic Sclerosis
Iloprost
Published in: Clinical Rheumatology / Issue 9/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05128-x

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2020

A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome

Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad

Cancer risks along the disease trajectory in antineutrophil cytoplasmic antibody associated vasculitis

The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs

Persistent chikungunya arthritis in Roraima, Brazil

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page